The timeline is pretty exciting to see, positive cashflow in Q1, uplisting in Q1-Q2, Human CGM testing in Q2-Q3, a major study in December and a pet food partnership in Q1-Q2. Not to mention a US relaunch in January and it looks like they are going to the two largest veterinary conferences in January and February. I wonder if they will have their own booth or if they will do something jointly with Covetrus? I see Covetrus registered for both but I dont see ALRT or GluCurve registered yet on either floorplan...
News 
Market Data 
Discover 
